📄 Direct examination of Gregory Matheson (part 1) — Thursday, May 4, 1995
Address:
C:\DEPT103\CRIMINAL\1995\MAY\4\DIRECT-EXAMINATION-OF-GREGORY-.DOC
TRIAL
▲ Day 67 of 167

Direct examination of Gregory Matheson (part 1)

Witness: Gregory Matheson
Examiner: Hank Goldberg
Called by: Prosecution • Date: Thursday, May 4, 1995 • Utterances: 300
Goldberg conducts redirect examination of LAPD criminalist Gregory Matheson, rehabilitating his EAP blood-typing testimony after a defense cross-examination centered on scientific literature. Matheson walks through four forensic science articles (Zajac/Grunbaum, Wraxall/Emes, Sensabaugh, Yeshion), explaining that none of them undermined his conclusion that fingernail scrapings from Nicole Brown's body likely showed a degraded BA type reading as B. He then introduces electrophoretogram exhibits showing item 42 (pool of blood under Nicole's body) yielded an inconclusive weak-B result, which he argues supports the degradation theory since Nicole was a known BA type.
1 MR. GOLDBERG:

Thank you, Mr. Harris, too.

2 MR. GOLDBERG:

Now, Mr. Matheson, you were also asked about an article by the name of--by the authors of Zajac, Z-A-J-A-C, Grunbaum, G-R-U-N-B-A-U-M, and Crim, C-R-I-M; is that correct?

3 MR. MATHESON:

Yes.

4 MR. GOLDBERG:

And is this an article that came out after the one that we just discussed, the Wraxall and Emes article?

5 MR. MATHESON:

I believe so, yes.

6 MR. GOLDBERG:

And is this the article that previously you testified said that: "inherent characteristics of the EAP system give rise to the possibility of very serious errors in phenotyping on other than fresh blood, especially if the history of the sample is not fully known"?

7 MR. MATHESON:

Yes, it is.

8 MR. GOLDBERG:

Now, in this particular article on page 615--

9 THE COURT:

This is Zajac?

10 MR. GOLDBERG:

Yeah.

11 MR. GOLDBERG:

--did they make reference to the Wraxall and Emes article that you were asked about on cross-examination that we just discussed?

12 MR. MATHESON:

Yes, I believe it does.

13 MR. GOLDBERG:

And did they distinguish the Wraxall and Emes article as dealing with a different situation from the situation that they were discussing in their article?

14 MR. MATHESON:

Yes.

15 MR. GOLDBERG:

Can you read for us what they said in order to distinguish Wraxall and Emes from their article?

16 MR. MATHESON:

Yes. In referencing the Wraxall and Emes article they followed that up with stating: "apparently the blood stains they used were prepared under laboratory conditions and the history and drying and preservation were well-known."

17 MR. GOLDBERG:

And in Grunbaum were they trying to give an idea as to what would happen to wet samples that were not prepared under laboratory conditions?

18 MR. BLASIER:

Objection. Calls for speculation.

19 THE COURT:

Leading.

20 MR. GOLDBERG:

Well, in the article what did they say? What kind of stains were they dealing with here?

21 MR. MATHESON:

Okay. The comment they made is that: "the preparation of their blood samples were done in such a way to simulate the diverse conditions which may take place in actual case work submitted to a crime lab."

22 MR. GOLDBERG:

Now, with respect to the--their article, did they identify the same degradation route that you just described that was discussed in the Wraxall and Emes?

23 MR. MATHESON:

I don't believe it was specifically delineated there.

24 MR. GOLDBERG:

Did they say--how did they characterize--can you read for us how they characterized the problems of misidentification that occurred in this particular study with the samples that they created?

25 MR. MATHESON:

It states: "the problem with misidentification of the samples in this study was not due to weak or indistinct band patterns, rather, discreet bands were present and readable but they had been altered to indicate erroneous phenotypes."

KEY QUOTE
26 MR. GOLDBERG:

Okay. And how did you interpret that, Mr. Matheson?

27 MR. MATHESON:

Well, again, that the system has degradation problems and that multiple bands can be read still and misinterpreted.

28 MR. GOLDBERG:

You mean even if you have discreet band patterns such as two B bands?

29 MR. MATHESON:

I believe that indicates that.

30 MR. GOLDBERG:

Now--

31 (Discussion held off the record between the Deputy District Attorneys.)
32 MR. GOLDBERG:

Could I see 1141-G, Mr. Harris? Is that possible? And then I want to see h and i.

33 MR. GOLDBERG:

Okay. I want to go back to the Wraxall and Emes article and the degradation route that they discussed. What does this represent when we are looking at the BA block diagram?

34 MR. MATHESON:

It represents a general location of the bands of a type BA.

35 MR. GOLDBERG:

All right. And the B block diagram?

36 MR. MATHESON:

It also represents the general location of the bands of a type B though in neither case does it give any sort of indication of the intensity differences.

37 MR. GOLDBERG:

And then let's see--let's see. This is H. Can we see u? When you said that they don't give an indication of the intensity differences, you mean what?

38 MR. MATHESON:

Well, that is one of the ways of determining the types, is particularly between a B and a C, is how intense certain bands are, and these are just all being blocked as approximately the same size, as opposed to the People's chart on EAP which does define the different intensities by the different sizes of the bands.

39 MR. GOLDBERG:

Now, can you tell us what we are looking at here in terms of the degradation route?

40 MR. MATHESON:

This is consistent with the degradation route described in the Wraxall article.

41 MR. GOLDBERG:

And that is what?

42 MR. MATHESON:

That you lose the bands from the anodal side or the positive side towards the cathodal side or the negative side, the low side.

43 MR. GOLDBERG:

Can you orient this just verbally in relationship to the People's chart, the six EAP diagrams on the block diagram just to show us how the two would interrelate?

44 MR. MATHESON:

If you--excuse me. If you were to turn the chart that is being projected up ninety degrees to the left so that the arrow would indicate the origin or the cathodic side.

45 MR. GOLDBERG:

And can we see the next--it would be this--on the list, please.

46 MR. GOLDBERG:

And now what does this show?

47 MR. MATHESON:

It is the final step in the degradation route that is described in the Wraxall article where what originally started out as a BA, the only thing that is left is the b1 band.

48 MR. GOLDBERG:

But are you saying that this degradation route that you were asked about is not the only one that you have seen or that is in the literature?

49 MR. MATHESON:

That's correct.

50 THE COURT:

All right. This is 1141. Is this v? V, as in victor. The previous one was 1141-U.

51 (Discussion held off the record between the Deputy District Attorneys.)
52 MR. GOLDBERG:

Thank you. Okay. Thank you, Mr. Harris.

53 MR. GOLDBERG:

Now, the--another one of the articles, the three articles that you were asked about, was the Yeshion--excuse me. Let me ask you about the Sensabaugh article first. Did the Sensabaugh article contain a broad base study of the phenomena of EAP disintegration or were they looking at only one stain when they discussed this degradation route, the one that we just saw on the Defense?

54 MR. MATHESON:

It appears by reading that article that when they are referencing that degradation route that has been described in the Wraxall article that just two bloodstains were used, one of a type B and one of a type BA.

55 MR. GOLDBERG:

All right. And then finally the Yeshion article that was referenced. Did the Yeshion article contain what purported to be a study of the phenomena of BA disintegration to B?

56 MR. MATHESON:

No, it did not.

57 MR. GOLDBERG:

What was that?

58 MR. MATHESON:

It was a technical note regarding the degradation of a B to a CB. I don't know if it then carried on to a C, but the a allele was not mentioned.

59 MR. GOLDBERG:

So Yeshion was not actually studying--did not purport to be studying the BA to B phenomenon to say--

60 MR. MATHESON:

That's correct.

61 MR. GOLDBERG:

She was studying other EAP issues with respect to degradation?

62 MR. MATHESON:

I don't know about studying. She was referencing other issues, yes.

63 MR. GOLDBERG:

Now, with respect to all four of the articles that we have mentioned so far, the Wraxall and Emes, the Grunbaum and Zajac, the Sensabaugh and the Yeshion article, considered together did you take those articles as some sort of a cautionary statement to the forensic analyst with respect to the EAP system?

64 MR. MATHESON:

Yes, I did.

65 MR. GOLDBERG:

So how?

66 MR. MATHESON:

And that is having--every one of them indicates that the EAP enzyme, unlike the other ones, does in fact degrade and that a degradation can lead to mistyping so you have to be careful about how you interpret EAP results.

67 MR. GOLDBERG:

Now, when you were asked about the Wraxall and Emes--well, let me ask you another question first. This book that you alluded to during your direct examination, what was the book?

68 MR. MATHESON:

It is the forensic science handbook by Richard Saferstein.

69 MR. GOLDBERG:

And was there a particular portion of that book that you referenced in particular in forming the opinions that you expressed on the witness stand with respect to the BA to B phenomena?

70 MR. MATHESON:

It enforced my knowledge of that, yes.

71 MR. GOLDBERG:

Can you tell us which portion you looked at?

72 MR. MATHESON:

It was a section that was written by Dr. Sensabaugh.

73 MR. GOLDBERG:

Maybe you can give us a page number because I believe counsel may have a copy of that?

74 MR. MATHESON:

Well, it is chapter 8 that starts on page 338. The area that we are referencing, I believe the paragraph starts on 369, and concludes on 370.

75 THE COURT:

Do you have that, Mr. Blasier?

76 MR. BLASIER:

If I may look for a minute.

77 (Brief pause.)
78 THE COURT:

Mr. Goldberg.

79 MR. GOLDBERG:

And did Wraxall--did Mr. Sensabaugh, in this chapter that he authored, mention the Wraxall and Emes or what we have discussed as being the Wraxall and Emes degradation route?

80 MR. MATHESON:

Yes, it does.

81 MR. GOLDBERG:

Did he say that that was the only degradation route?

82 MR. MATHESON:

I don't believe so, no.

83 MR. GOLDBERG:

Can you tell us what he said?

84 MR. MATHESON:

Well, he makes reference to the stabilities of the isoenzymes, the different types. One quote here is that: "the a isoenzymes are the least stable and the c isoenzymes the most stable, thus one might expect the a bands in BA and ca types to be lost before the B or c bands are lost and this in fact has been observed."

85 MR. GOLDBERG:

And does he say--

86 MR. BLASIER:

I'm going to object unless the rest of that paragraph is read.

87 THE COURT:

Mr. Goldberg.

88 MR. GOLDBERG:

I don't know what the legal basis of the objection is.

89 THE COURT:

I think it is 256.

90 MR. GOLDBERG:

What?

91 THE COURT:

256, I believe.

92 MR. GOLDBERG:

Sir, can you read the rest of the paragraph?

93 MR. MATHESON:

I will be happy to.

94 MR. GOLDBERG:

Sure.

95 MR. MATHESON:

"in typing aged type BA bloodstains, for example, only the major B band, the anodal B band, may be apparent and the temptation would be to type the sample as a B to avoid error of this sort. Empirical rules for typing interpretation need to be invoked since it has been observed that in aged BA bloodstains the slow B band is generally lost before the fast a band. The controlling rule is to withhold judgment on a putative B type until both B bands are apparent. If the sample is in fact a BA type, the major a band should be apparent by that time."

96 MR. GOLDBERG:

Now, did Mr. Sensabaugh identify any particular degradation route that is different from the Wraxall and Emes degradation route?

97 MR. MATHESON:

I feel that this article or this--excuse me--this paragraph actually mentions a couple of different routes or discrepancies between the possible ways the degradation can occur.

98 MR. BLASIER:

Objection, move to strike as nonresponsive.

99 THE COURT:

Overruled.

100 MR. GOLDBERG:

How so? What other degradation route is identified there?

101 MR. MATHESON:

Well, in one sentence he states that: "in type aged type BA bloodstains, for example, only the major B band or the anodal B band," this is the anodal or the one closest to the anode side, as opposed to this band, which is the cathodal or the closest to the origin, "may be apparent." he is saying that at some point it is possible that only the major bands or the brightest band might be present.

102 MR. GOLDBERG:

How is that different from the Wraxall and Emes?

103 MR. MATHESON:

In their study they saw the degradation route so that the cathodal band was the last one that was apparent.

104 MR. GOLDBERG:

Let's just cover up the a bands for a moment so that we can make them understanding. On the BA chart forward I have just put the covers back over on the a band on the BA phenotype.

105 THE COURT:

Yes.

106 MR. GOLDBERG:

So according to the Wraxall and Emes study, they are saying that which band would remain after the sample had degraded?

107 MR. MATHESON:

The most cathodal one or the one closest to the origin.

108 MR. GOLDBERG:

And the one that is on the right side of this diagram?

109 MR. MATHESON:

That's correct.

110 MR. GOLDBERG:

And in this portion that you just read to us that Sensabaugh is saying which?

111 MR. MATHESON:

In that one portion there he makes reference to what he calls the major B band--excuse me--or the cathodal B band or--excuse me--the anodal B band may be apparent.

112 MR. GOLDBERG:

And does he say that these degradation routes, that it always occurs in either of these two ways?

113 MR. MATHESON:

I didn't read that in there, no.

114 MR. GOLDBERG:

Does he say that--that these are general ways that they happen, that this is how it generally happens?

115 MR. MATHESON:

There is the term "generally used," yes.

116 MR. GOLDBERG:

So in interpreting that, did you, as a forensic analyst, take that to mean that this is the only path, degradation path, that this marker will take, or that this is one of the degradation paths that this marker will take?

117 MR. BLASIER:

Objection, leading.

118 THE COURT:

Sustained. Rephrase the question.

119 MR. GOLDBERG:

How did you take that term, that this generally, generally take these two paths?

120 MR. MATHESON:

On reading that paragraph and the discrepancies between the different types, it indicates to me that there may be more than one way that degradation can occur.

121 MR. GOLDBERG:

And did you take the totality of the articles and the book that you just referenced, and also the source book that I think you referenced earlier in your cross-examination, as providing some sort of cautionary statement to the forensic analyst when trying to type a B and distinguishing it from a BA?

122 MR. MATHESON:

Yes.

123 MR. GOLDBERG:

And what was that?

124 MR. MATHESON:

Again, in general, that this is an enzyme that has degradation problems and you just have to be careful about the interpretation of the results.

125 MR. GOLDBERG:

Did anything that you read in these articles, Mr. Matheson, cause you to change the statement that you made initially on your analyzed evidence report that you could not exclude the possibility with respect to the fingernail scrapings it was a BA that degraded into a B?

126 MR. MATHESON:

No, it did not.

127 MR. GOLDBERG:

Did anything that was brought up during cross-examination by the Defense cause you to change the opinion that you have offered on direct that probably the samples underneath the fingernails were a BA that degraded to appear to be a B?

128 MR. MATHESON:

I'm not sure about--

129 MR. BLASIER:

Objection. Misstates the testimony, your Honor.

130 THE COURT:

Sustained.

131 MR. GOLDBERG:

What was your opinion, your bottom line opinion, when you considered all of the facts of this case as you are aware of them, including the photographs of where the victim's body was, the pool of blood, item no. 42, and the other tests that you did? What was your opinion as to the fingernail scrapings?

132 MR. MATHESON:

Well, the result does not change. I did see a B, but in considering absolutely everything, I would have to say that it is a likelihood that the blood that was found under the fingernails were in fact from Ms. Brown and had degraded. But again, I cannot totally eliminate the possibility that it is a b.

133 MR. GOLDBERG:

Okay. Now, did anything that was brought up during cross-examination cause you to change that opinion or reevaluate that opinion?

134 MR. MATHESON:

No, it did not.

135 MR. GOLDBERG:

Now, sir, with respect to resolving this issue, is it possible to look at a control study from the scene?

136 MR. MATHESON:

I don't know if it totally resolves it, but it does lend credence to the possibility that you have degradation occurring.

137 MR. GOLDBERG:

And what does that mean, using the control study?

138 MR. MATHESON:

If--if you are typing or if you test another blood sample that is of a known source or that you believe to be of a known source from the scene and it shows a similar type of degradation that you have seen in the past and experienced and that that possibility exists in your sample, then I believe it is important to take that into consideration.

139 MR. GOLDBERG:

Now, is this idea of looking at a control study, such as a pool of blood underneath the victim, something that was reflected in science--in forensic science literature, that you considered prior to your testimony here?

140 MR. MATHESON:

Well, I had that opinion prior to this; however, I have read an article that enforces my opinion about that.

141 (Discussion held off the record between the Deputy District Attorneys.)
142 MR. GOLDBERG:

Oh, here. I had it right in my hand.

143 MR. GOLDBERG:

Okay. Specifically, sir, did you look at an article by Bruce Budowle and Robert Allen entitled "electrophoresis reliability, the contaminant issue"?

144 MR. MATHESON:

Yes, I did.

145 MR. GOLDBERG:

And I direct your attention to page 1546.

146 THE COURT:

Mr. Blasier, do you have this article?

147 MR. BLASIER:

I don't.

148 MR. GOLDBERG:

We cited this in one of our papers, your Honor. (Brief pause.)

149 MR. GOLDBERG:

Now, sir is this dealing with the EAP issue, per say, or is this dealing more broadly with various contaminant issues in electrophoresis and problem resolving in electrophoresis?

150 MR. MATHESON:

It is dealing with electrophoresis reliability in general, not just with the EAP.

151 MR. GOLDBERG:

Can you tell us--can you read for us the portion of the Budowle article that suggests looking at a control study from the scene and trying to provide more information about what is happening at the scene?

152 (No audible response.)
153 MR. GOLDBERG:

Portion that I have bracketed off?

154 MR. MATHESON:

It starts with: "furthermore, the competent and experienced forensic scientists do not work in a vacuum. It should be stressed that the analyst gathers as much information as possible regarding the case," then in parenthesis, "and potential influence such as contaminant" close paren, "to evaluate properly the data obtained from evidentiary material. More importantly, in reality, an ideal control study is naturally provided to forensic scientists. This is the electrophoretic analysis of victim's blood on victim's clothing and other substrata. The blood shed by a victim onto his or her own clothing and surrounding substrata is exposed to the same myriad of environmental insults as other questioned stains submitted to the laboratory for electrophoretic analysis. The accuracy of electrophoretic typing of the questioned sample can be independently verified with the victim's whole blood."

155 MR. GOLDBERG:

And sir, what was your interpretation of that in terms of using a control study to resolve issues as to what is happening in a crime scene?

156 MR. MATHESON:

Well, that confirmed a policy that we have had as far as collecting a known blood sample from the scene from each of the victims and that information from that can be used to consider information derived from other samples.

157 MR. GOLDBERG:

And sir, is that why in expressing certain opinions in Court on direct examination regarding this EAP issue, you considered test results on the pool of blood underneath Nicole Brown, item 42?

158 MR. MATHESON:

Yes, that's correct.

159 MR. GOLDBERG:

Maybe we can see the serology results board.

160 (Brief pause.)
161 MR. GOLDBERG:

Now, Mr. Matheson, when you considered those test results on 42, were those test results inconclusive?

162 MR. MATHESON:

Yes, they were.

163 MR. GOLDBERG:

And were you reporting those test results--let me wait until we put the board up. Maybe it will make it a little easier.

164 (Brief pause.)
165 MR. GOLDBERG:

That is People's 202.

166 (Brief pause.)
167 MR. GOLDBERG:

Okay. Directing your attention to the item that says 42, "blood under Nicole Brown," under the EAP column it says, "inconclusive B very weak"; is that correct?

168 MR. MATHESON:

Yes, it does.

169 MR. GOLDBERG:

And were you reporting this inconclusive result for the purposes of suggesting that it was correct, in other words, that the blood was in fact a type B blood?

170 MR. MATHESON:

Well, I did not report a type at all for that. My report reflects inconclusive.

171 MR. GOLDBERG:

I'm sorry, my terminology was wrong. When you were testifying about this result, were you testifying about it for the purposes of suggesting that the inconclusive B was--was a direct result in the sense that the blood really was a type B?

172 MR. MATHESON:

No, I was not.

173 MR. GOLDBERG:

So what was your purpose in considering this and testifying about this and giving your explanations about the EAP results under the fingernails?

174 MR. MATHESON:

Okay. The inconclusive, like I mentioned, no activity would be you are not seeing anything on the gel. A result that is reported is a definitive result, it is what you are seeing occurring on that gel. An inconclusive falls somewhere in between. It is a pretty broad range. It could be just almost possible to call but you are not quite sure, there is something about it, or it could be something that is very vague, just kind of a blurry occurrence. In this case I observed what I thought might be a B, it wasn't good enough to call. I am not going to say for a fact that it is a B, but it occurred in an area and on a sample that we are assuming to be from a particular person and thus of a particular type. We know her for a fact to be a type BA and the fact that this is an inconclusive B shows that there is something going on with this blood and with the sample and that the results should be interpreted carefully.

175 MR. GOLDBERG:

Your Honor, at this time I would like to mark two more exhibits and they are similar to--in fact, just smaller versions of the ones that the Defense marked.

176 (Brief pause.)
177 MR. GOLDBERG:

And People's next in order 224.

178 THE COURT:

224.

179 MR. GOLDBERG:

Can I mark them as 224-A and 224-B?

180 THE COURT:

Yes.

181 MR. GOLDBERG:

And a is what appears to be an electrophoretogram and has the numbers 1304.

182 (Peo's 224-A for id = electrophoretogram)
183 (Peo's 224-B for id = electrophoretogram)
184 (Discussion held off the record between the Deputy District Attorneys.)
185 THE COURT:

And Mr. Blasier, you are familiar with both of these?

186 MR. BLASIER:

I am, but I would like to just briefly look at them.

187 MR. GOLDBERG:

And 224-B is 13--excuse me--7310.

188 (Discussion held off the record between the Deputy District Attorneys.)
189 THE COURT:

All right.

190 MR. GOLDBERG:

Now--

191 THE COURT:

Would you show those to Mr. Blasier real quick.

192 MR. GOLDBERG:

When you were talking about item no. 42 just a few moments ago, what is the purpose of collecting that item again?

193 THE COURT:

I think we've asked this a couple times.

194 MR. BLASIER:

Asked and answered.

195 MR. GOLDBERG:

So sir, when you were saying that you were assuming that that is the victim's blood, that is based on what?

196 MR. MATHESON:

The location from where it was collected.

197 MR. GOLDBERG:

Okay. And is that why this type of sample is collected?

198 MR. MATHESON:

Yes.

199 MR. GOLDBERG:

Sir, I would now like to show you People's 224-A and 224-B. Showing you 224-A first, what is that?

200 MR. MATHESON:

224-A is a copy of a photograph of my electrophoresis run, no. 7309, which contains, among other items, the fingernail scrapings, 84-A and 84-B.

201 MR. GOLDBERG:

Okay. And 224-B is?

202 MR. MATHESON:

224-B is another photograph of a photograph of electrophoresis run no. 7310 which includes, among other things, the results of item no. 42.

203 MR. GOLDBERG:

Now, on 224-B for identification, I would like to perhaps if I could put it on the elmo and then maybe pass it around, but I would like the witness to write something on it first.

204 MR. GOLDBERG:

Could you identify for us, just by writing on the bottom of the photograph, where 42 is?

205 MR. MATHESON:

It is in position 4 and putting an arrow up from the bottom above the number "42."

206 MR. GOLDBERG:

Now, putting 224-B on the elmo.

207 (Brief pause.)
208 MR. GOLDBERG:

Can we see that part of the photograph that has the number on it?

209 (Brief pause.)
210 MR. GOLDBERG:

We need to see the white part at the bottom.

211 MR. GOLDBERG:

Okay. So have you written in where 42 is?

212 MR. MATHESON:

Yes, I have.

213 MR. GOLDBERG:

And is one of the reasons that you considered this, that logically a pool of the victim's blood should contain the victim's blood?

214 MR. MATHESON:

Yes.

215 MR. GOLDBERG:

So without testing it, would have you have expected this to look like a BA?

216 MR. MATHESON:

Yes, I would have.

217 MR. GOLDBERG:

But when you tested it, what did it look like?

218 MR. MATHESON:

It gave a weak result that eventually ended up being called inconclusive, but I saw the two B bands very, very lightly, kind of fuzzy clouds in the areas where you would expect to see them.

219 MR. GOLDBERG:

Maybe we can just with directing the arrows printout where those are.

220 MR. MATHESON:

Okay. You need to go up, move the arrow to the left, now to the right. It can lay right on top of that other band and that is pointing right into the lower B band. That is fine. Right there, (Indicating).

221 MR. GOLDBERG:

Okay. Just put another arrow pointing to the upper B band.

222 MR. MATHESON:

If you go directly above the arrow that was previously placed by two bands, go up, up, up, down a little bit, right about in there, (Indicating), is the other B band.

223 MR. GOLDBERG:

I know it is hard to see on the elmo, Mr. Matheson, but when you look at this plate, do you see any distinct band pattern in either of the two a regions?

224 MR. MATHESON:

For that item?

225 MR. GOLDBERG:

Yes.

226 MR. MATHESON:

No, I do not.

227 MR. GOLDBERG:

But do you see a band pattern in the two B regions?

228 MR. MATHESON:

I see something that has kind of a band-like appearance. It is not a good band. If it was, I would have had called it.

229 MR. GOLDBERG:

All right. Now, assuming this is in fact a BA, using the Wraxall and Emes degradation route, if we assume that were the only degradation route, would you expect to see this?

230 MR. MATHESON:

No, I would not.

231 MR. GOLDBERG:

Why not?

232 MR. MATHESON:

Because if this is in fact a BA, as you are assuming, then I would expect to still see that lower a band in addition to the two B bands.

233 MR. BLASIER:

I'm going to object. This mischaracterizes this exhibit. I see a band there.

234 THE COURT:

Overruled.

235 MR. GOLDBERG:

Now, Mr. Matheson--by the way, how many years do you have of experience in total looking at these banding patterns?

236 MR. MATHESON:

Approximately twelve years.

237 MR. GOLDBERG:

And you are saying that there are only two distinct--I'm sorry. You didn't see two bands but only two band-like patterns on this object.

238 MR. BLASIER:

Objection. Mischaracterizes his testimony. He said it was not a band.

239 THE COURT:

Sustained. Rephrase the question.

240 MR. GOLDBERG:

There are only two patterns; is that correct, in that lane?

241 MR. MATHESON:

I'm seeing what appears to be two very weak band-like appearances in those areas. This is a very weak sample, difficult to read.

242 MR. GOLDBERG:

Now, can we--can we print this out as People's 224--

243 THE COURT:

C.

244 MR. GOLDBERG:

--C.

245 (Peo's 224-C for id = photograph)
246 MR. GOLDBERG:

Your Honor, with the Court's permission could we show this to the jury, because the resolution on our elmo isn't that great?

247 THE COURT:

Yes.

248 MR. GOLDBERG:

And just before I show them, Mr. Matheson, so that the--so that we know what we are looking for, you wrote a 42 on the lane that represents 42; is that correct?

249 MR. MATHESON:

Yes, I did.

250 MR. GOLDBERG:

Pointing up? And the--well, maybe we can also pass around the printout, too, so that they can just compare.

251 THE COURT:

May I see that, please?

252 MR. GOLDBERG:

Sure.

253 (Brief pause.)
254 MR. BLASIER:

I object to the printout being passed around. I have no objection to the photograph.

255 MR. GOLDBERG:

Well, I just think the printout might be helpful in identifying where to look.

256 MR. BLASIER:

I disagree.

257 THE COURT:

All right. The objection is overruled.

258 (Brief pause.)
259 MR. GOLDBERG:

Still waiting for the printout, your Honor.

260 (Discussion held off the record between the Deputy District Attorneys.)
261 MR. GOLDBERG:

Your Honor, perhaps with the Court's permission, I might be able to ask a couple questions.

262 THE COURT:

Please do.

263 MR. GOLDBERG:

Yeah, thank you.

264 THE COURT:

I would like to finish with Mr. Matheson today, if we could.

265 MR. GOLDBERG:

Your Honor, I would like to mark as People's next in order 225 and I may also be marking a 224-D later on, but as 225, a document that says "electrophoresis work sheet."

266 THE COURT:

Mr. Blasier, do you have a copy of this?

267 MR. GOLDBERG:

Contains 41, 42--it is l-387.

268 MR. BLASIER:

I do.

269 THE COURT:

All right.

270 (Peo's 225 for id = electrophoresis work sheet)
271 MR. GOLDBERG:

Mr. Matheson, while he we are waiting for the printout, can you just tell us what l-387 is?

272 MR. MATHESON:

L-387 is a photocopy that actually is slightly crooked, cuts off part of the left-hand column of one of my electrophoresis work sheets that corresponds to photo no. 7310.

273 MR. GOLDBERG:

And on this particular work sheet you called item no. 84, the fingernails, as a B what?

274 MR. MATHESON:

This work sheet does not have 84 on it.

275 MR. GOLDBERG:

That doesn't have 84. Does that have 42 on it?

276 MR. MATHESON:

Yes, it does.

277 MR. GOLDBERG:

And what was 42 called as?

278 MR. MATHESON:

A B question mark inc for inconclusive. The second reading on that was a na for no activity.

279 (Discussion held off the record between the Deputy District Attorneys.)
280 MR. GOLDBERG:

I just want to perhaps put this on the elmo one more time, if I may, before I give it to the jury. This is 224-B. I'm not going to mark on it or make a printout.

281 THE COURT:

Do we have to see it again?

282 MR. GOLDBERG:

I want to make sure everyone knows where to look.

283 THE COURT:

I think the arrow there is apparent in the lane.

284 MR. GOLDBERG:

Okay.

285 MR. GOLDBERG:

Now, sir, between the--in the arrow--the arrow is pointing to an area that I guess on the photograph would be about a quarter to a half of an inch above it that is sort of a bright band. Where is the band that we are looking for in relationship to that?

286 MR. MATHESON:

Well, it is in that same--

287 MR. BLASIER:

Objection, mischaracterizes the testimony.

288 THE COURT:

Sustained.

289 MR. GOLDBERG:

What?

290 THE COURT:

Band.

291 MR. GOLDBERG:

Well, I'm referring to the--

292 MR. GOLDBERG:

Do you see these very, very bright hash marks that go all the way across the bottom part of the photograph?

293 MR. MATHESON:

Oh, I'm sorry, yes, I do.

294 MR. GOLDBERG:

And there is one of those hash marks--there is an arrow that has no. 42 and the arrow is pointing to one of the hash marks?

295 MR. MATHESON:

Yes.

296 MR. GOLDBERG:

Okay. Where in relationship to that hash mark is the lane that constitutes 42?

297 MR. MATHESON:

42 is directly above the arrow. It is a lane about three eights of an inch wide directly above the arrow.

298 MR. GOLDBERG:

Thank you. I'm sure hash mark probably wasn't the scientifically correct term, but--

299 (The exhibits were passed amongst the jury.)
300 MR. GOLDBERG:

Your Honor, could we approach for one moment off the record while the jury is looking at this?

Temperature

procedural

Key Quotes (4)

Gregory Matheson
I would have to say that it is a likelihood that the blood that was found under the fingernails were in fact from Ms. Brown and had degraded. But again, I cannot totally eliminate the possibility that it is a b.
Matheson's bottom-line opinion on the fingernail scrapings, maintained after cross-examination — he is confident it is degraded BA but hedges appropriately
Gregory Matheson
We know her for a fact to be a type BA and the fact that this is an inconclusive B shows that there is something going on with this blood and with the sample and that the results should be interpreted carefully.
Core argument for using item 42 as a degradation control: the victim's own blood pool showed the same degradation pattern, lending credibility to the fingernail interpretation
Gregory Matheson
The problem with misidentification of the samples in this study was not due to weak or indistinct band patterns, rather, discreet bands were present and readable but they had been altered to indicate erroneous phenotypes.
Reading from the Grunbaum/Zajac article — establishes that even clear-looking bands can represent mistyped degraded samples, directly rebutting defense's implication that clean results are reliable
Gregory Matheson
The controlling rule is to withhold judgment on a putative B type until both B bands are apparent. If the sample is in fact a BA type, the major a band should be apparent by that time.
Reading from Sensabaugh's chapter — the very literature the defense cited contains an empirical rule supporting caution in calling B vs. BA, consistent with Matheson's approach

Evidence (11)

People's 1141-G, H, I, U, V
Block diagrams illustrating BA and B EAP phenotypes and the Wraxall/Emes degradation route, showing band positions
discussed, displayed on ELMO to illustrate degradation pathway
People's 202
Serology results board showing EAP results for all items including item 42 ('inconclusive B very weak')
displayed for reference to item 42 results
People's 224-A
Photograph of electrophoretogram run 7309 containing fingernail scrapings items 84-A and 84-B
introduced, identified by Matheson
People's 224-B
Photograph of electrophoretogram run 7310 containing item 42 (pool of blood under Nicole Brown's body); Matheson annotated lane position
introduced, annotated, displayed on ELMO, passed to jury
People's 224-C
Printout of 224-B photograph
introduced, passed to jury over partial defense objection
People's 225
Electrophoresis work sheet L-387 for run 7310, showing item 42 called as 'B? inc' (inconclusive) then 'na' (no activity)
introduced and identified
+ 5 more

Notable Exchanges (3)

Hank GoldbergGregory MathesonRobert Blasier
Goldberg walked Matheson through the Sensabaugh paragraph; Blasier invoked Evidence Code 256 (completeness) to require the full paragraph be read, which Matheson then did — the complete passage actually supported Matheson's position that multiple degradation routes exist.
strategic
Hank GoldbergRobert BlasierLance A. Ito
Blasier repeatedly objected that Goldberg's questions mischaracterized Matheson's testimony about band patterns on item 42 (calling faint smears 'bands'). Two of these objections were sustained, forcing Goldberg to rephrase.
procedural sparring
Hank GoldbergGregory Matheson
Matheson explained item 42 in detail: he saw weak cloud-like patterns in the B regions but no activity in the 'a' regions, and called it inconclusive — not as evidence that it was truly type B, but as a control showing the victim's own blood was degrading at the scene.
revealing

Light Moments (1)

Hank Goldberg
After directing Matheson to the bright horizontal marks at the bottom of the photograph as reference points, Goldberg acknowledged: 'I'm sure hash mark probably wasn't the scientifically correct term, but—'

Witness Demeanor

(Discussion held off the record between the Deputy District Attorneys.) [multiple times during exhibit handling]
(Brief pause.) [repeated during exhibit logistics]
(The exhibits were passed amongst the jury.)

Objections

9 objections (4 sustained, 4 overruled)
Proceeding 5923 • 300 utterances • Prosecution witness
Criminal Trial
Department 103
⚖️ Start
📂 MAY 4, 1995 📄 Direct examination of Gregory
MAY 4, 1995 KRT DvH TD